iSpecimen (ISPC) Asset Writedowns and Impairment (2021 - 2026)
iSpecimen (ISPC) recorded quarterly Asset Writedowns and Impairment of $368.0 in Q1 2026, down 99.98% quarter-over-quarter from $1.9 million in Q4 2025, and down 99.67% on a YoY basis from $111041.0 in Q1 2025.
iSpecimen (ISPC) Asset Writedowns and Impairment (2021 - 2026) Analysis & Trends
iSpecimen's Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $368.0 for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 99.67% year-over-year to $368.0; the TTM figure through Mar 2026 stood at $1.8 million (up 184.47% YoY), while the FY2025 annual figure was $1.9 million, up 165.13% from the prior year.
- Asset Writedowns and Impairment was $368.0 for Q1 2026 at iSpecimen, down from $1.9 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $1.9 million in Q4 2025 to a low of -$234277.0 in Q4 2022.
- Historically, Asset Writedowns and Impairment has averaged $175810.4 across 5 years, with a median of $71213.0 in 2022.
- The sharpest annual moves came in 2022 and 2025: Asset Writedowns and Impairment soared 1335.91% in 2022, then tumbled 1519.12% in 2025.
- A 5-year view of Asset Writedowns and Impairment shows it stood at -$234277.0 in 2022, then soared by 126.46% to $61986.0 in 2023, then surged by 706.57% to $499960.0 in 2024, then soared by 271.43% to $1.9 million in 2025, then sank by 99.98% to $368.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $368.0 (Q1 2026), $1.9 million (Q4 2025), and -$3521.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn |
| 10 | iSpecimen | 1.02 Mn | -1.79 Mn | -1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 368.00 |
| Mar 31, 2026 | 368.00 |
| Dec 31, 2025 | 1.86 Mn |
| Dec 31, 2025 | 1.86 Mn |
| Sep 30, 2025 | -3,521.00 |
| Sep 30, 2025 | -3,521.00 |
| Jun 30, 2025 | -93,463.00 |
| Jun 30, 2025 | -93,463.00 |
| Mar 31, 2025 | 111,041.00 |
| Mar 31, 2025 | 111,041.00 |
| Dec 31, 2024 | 499,960.00 |
| Dec 31, 2024 | 499,960.00 |
| Sep 30, 2024 | 1,254.00 |
| Sep 30, 2024 | 1,254.00 |
| Jun 30, 2024 | 6,586.00 |
| Jun 30, 2024 | 6,586.00 |
| Mar 31, 2024 | 197,924.00 |
| Mar 31, 2024 | 197,924.00 |
| Dec 31, 2023 | 61,986.00 |
| Dec 31, 2023 | 61,986.00 |